Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | HBI-2438 |
Trade Name | |
Synonyms | HBI2438|HBI 2438 |
Drug Descriptions |
HBI-2438 selectively inhibits KRAS G12C, leading to decreased downstream signaling and potentially resulting in decreased tumor cell proliferation and inhibition of tumor growth (NCI Drug DIctionary, Mol Cancer Ther (2023) 22 (12_Supplement): A097). |
DrugClasses | KRAS G12C inhibitor 33 |
CAS Registry Number | NA |
NCIT ID | C190135 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HBI-2376 + HBI-2438 | HBI-2376 HBI-2438 | 0 | 0 |
HBI-2438 | HBI-2438 | 0 | 1 |